Van Doren, Jessica http://orcid.org/0000-0001-9042-8948
Arns, Martijn http://orcid.org/0000-0002-0610-7613
Heinrich, Hartmut http://orcid.org/0000-0002-8156-489X
Vollebregt, Madelon A.
Strehl, Ute
K. Loo, Sandra http://orcid.org/0000-0002-9108-0565
Article History
Received: 5 October 2017
Accepted: 5 February 2018
First Online: 14 February 2018
Compliance with ethical standards
:
: MA reports options from Brain Resource (Sydney, Australia); is director and owner of Research Institute Brainclinics, a minority shareholder in neuroCare Group (Munich, Germany), and a co-inventor on 4 patent applications (A61B5/0402; US2007/0299323, A1; WO2010/139361 A1; WO2017/099603 A1) related to EEG, neuromodulation and psychophysiology, but does not own these nor receives any proceeds related to these patents; Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia) and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn and Magventure; however, data analyses and writing of this manuscript were unconstrained. US has been paid for public speaking by Novartis, Medice, neuroCare, the German Society for Biofeedback, and Akademie König und Müller. All other authors have indicated no potential conflicts of interest relevant to this article to disclose.